{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:37:17Z","timestamp":1761489437896},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T00:00:00Z","timestamp":1408752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00213-014-3717-9","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T22:59:32Z","timestamp":1408661972000},"page":"807-813","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Distribution pattern of mirtazapine and normirtazapine in blood and CSF"],"prefix":"10.1007","volume":"232","author":[{"given":"Michael","family":"Paulzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone C.","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Veselinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Groppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,23]]},"reference":[{"issue":"3","key":"3717_CR1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000098654","volume":"54","author":"P Baumann","year":"2006","unstructured":"Baumann P, Jonzier-Perey M, Paus E, Nikisch G (2006) Mirtazapine enantiomers in blood and cerebrospinal fluid. Neuropsychobiology 54(3):179\u2013181","journal-title":"Neuropsychobiology"},{"issue":"5","key":"3717_CR2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.clpt.6100116","volume":"81","author":"J Brockm\u00f6ller","year":"2007","unstructured":"Brockm\u00f6ller J, Meineke I, Kirchheiner J (2007) Pharmacokinetics of mirtazapine: enantioselective effects of the CYP2D6 ultra rapid metabolizer genotype and correlation with adverse effects. Clin Pharmacol Ther 81(5):699\u2013707","journal-title":"Clin Pharmacol Ther"},{"key":"3717_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.47.120505.105237","volume":"47","author":"A Boer de","year":"2007","unstructured":"de Boer A, Gaillard P (2007) Drug targeting to the brain. Annu Rev Pharmacol Toxicol 47:323\u2013355","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"3717_CR4","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","volume":"56","author":"E Lange de","year":"2004","unstructured":"de Lange E (2004) Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 56(12):1793\u20131809","journal-title":"Adv Drug Deliv Rev"},{"key":"3717_CR5","doi-asserted-by":"crossref","unstructured":"de Lange EC (2013) Utility of CSF in translational neuroscience. J Pharmacokinet Pharmacodyn :1\u201312","DOI":"10.1007\/s10928-013-9301-9"},{"issue":"10","key":"3717_CR6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003088-200241100-00001","volume":"41","author":"ECM Lange de","year":"2002","unstructured":"de Lange ECM, Danhof M (2002) Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting. Clin Pharmacokinet 41(10):691\u2013703","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3717_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00044011-199815010-00006","volume":"15","author":"L Delbressine","year":"1998","unstructured":"Delbressine L, Moonen M, Kaspersen F, Wagenaars G, Jacobs P, Timmer C, Paanakker J, Van Hal H, Voortman G (1998) Pharmacokinetics and biotransformation of mirtazapine in human volunteers. Clin Drug Investig 15(1):45\u201355","journal-title":"Clin Drug Investig"},{"issue":"2","key":"3717_CR8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainresbull.2005.11.017","volume":"69","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen R, Vogt J, Lipfert P, Muth-Selbach U (2006) Mirtazapine and its enantiomers differentially modulate acute thermal nociception in rats. Brain Res Bull 69(2):168\u2013173","journal-title":"Brain Res Bull"},{"issue":"8","key":"3717_CR9","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","volume":"25","author":"M Hammarlund-Udenaes","year":"2008","unstructured":"Hammarlund-Udenaes M, Frid\u00e9n M, Syv\u00e4nen S, Gupta A (2008) On the rate and extent of drug delivery to the brain. Pharm Res 25(8):1737\u20131750","journal-title":"Pharm Res"},{"issue":"6","key":"3717_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gr\u00fcnder G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, M\u00fcller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44(6):195\u2013235","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"3717_CR11","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1023\/A:1015040217741","volume":"16","author":"J Kelder","year":"1999","unstructured":"Kelder J, Grootenhuis PDJ, Bayada DM, Delbressine LPC, Ploemen J-P (1999) Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 16(10):1514\u20131519","journal-title":"Pharm Res"},{"issue":"3","key":"3717_CR12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/jpet.111.180398","volume":"339","author":"H Kodaira","year":"2011","unstructured":"Kodaira H, Kusuhara H, Fujita T, Ushiki J, Fuse E, Sugiyama Y (2011) Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate. J Pharmacol Exp Ther 339(3):935\u2013944","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3717_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0006-3223(98)00078-X","volume":"45","author":"JT Little","year":"1999","unstructured":"Little JT, Ketter TA, Math\u00e9 AA, Frye MA, Luckenbaugh D, Post RM (1999) Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biol Psychiatry 45(3):285\u2013289","journal-title":"Biol Psychiatry"},{"issue":"8","key":"3717_CR14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","volume":"6","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H (2005) Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6(8):591\u2013602","journal-title":"Nat Rev Neurosci"},{"key":"3717_CR15","unstructured":"Merck (2009) REMERON (mirtazapine) tablets\u2014prescribing information"},{"issue":"2","key":"3717_CR16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1099\/vir.0.83345-0","volume":"89","author":"JD Morrey","year":"2008","unstructured":"Morrey JD, Olsen AL, Siddharthan V, Motter NE, Wang H, Taro BS, Chen D, Ruffner D, Hall JO (2008) Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. J Gen Virol 89(2):467\u2013473","journal-title":"J Gen Virol"},{"issue":"5","key":"3717_CR17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/JCP.0b013e3181f2288e","volume":"30","author":"G Nikisch","year":"2010","unstructured":"Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Math\u00e9 AA (2010) Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol 30(5):496\u2013503","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"3717_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.jcp.0000125680.89843.a6","volume":"24","author":"G Nikisch","year":"2004","unstructured":"Nikisch G, Math\u00e9 AA, Czernik A, Eap CB, Jim\u00e9nez-Vasquez P, Brawand-Amey M, Baumann P (2004) Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response. J Clin Psychopharmacol 24(3):283\u2013290","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"3717_CR19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00213-005-0034-3","volume":"181","author":"G Nikisch","year":"2005","unstructured":"Nikisch G, Math\u00e9 AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P (2005) Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology 181(4):751\u2013760","journal-title":"Psychopharmacology"},{"issue":"1","key":"3717_CR20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2165\/00003088-199528010-00004","volume":"28","author":"C Nordin","year":"1995","unstructured":"Nordin C, Bertilsson L (1995) Active hydroxymetabolites of antidepressants. Clin Pharmacokinet 28(1):26\u201340","journal-title":"Clin Pharmacokinet"},{"key":"3717_CR21","doi-asserted-by":"crossref","unstructured":"Paulzen M, Groppe S, Tauber SM, Veselinovic T, Hiemke C, Gr\u00fcnder G (2014) Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid. J Clin Psychiatry accepted for publication","DOI":"10.4088\/JCP.13m08921"},{"issue":"4","key":"3717_CR22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00007691-200408000-00005","volume":"26","author":"E Paus","year":"2004","unstructured":"Paus E, Ml J-P, Cochard N, Eap CB, Baumann P (2004) Chirality in the new generation of antidepressants: stereoselective analysis of the enantiomers of mirtazapine, N-demethylmirtazapine, and 8-hydroxymirtazapine by LC-MS. Ther Drug Monit 26(4):366\u2013374","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3717_CR23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1528-1167.2006.00504.x","volume":"47","author":"B Rambeck","year":"2006","unstructured":"Rambeck B, J\u00fcrgens UH, May TW, Wolfgang Pannek H, Behne F, Ebner A, Gorji A, Straub H, Speckmann EJ, Pohlmann\u2010Eden B (2006) Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 47(4):681\u2013694","journal-title":"Epilepsia"},{"issue":"3","key":"3717_CR24","first-page":"1","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z (2011) Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8(3):1\u201325","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"3717_CR25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0009-8981(87)90250-6","volume":"163","author":"H Reiber","year":"1987","unstructured":"Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163(3):319\u2013328","journal-title":"Clin Chim Acta"},{"issue":"13","key":"3717_CR26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/1568026043387692","volume":"4","author":"T Sakaeda","year":"2004","unstructured":"Sakaeda T, Nakamura T, Okumura K (2004) Pharmacogenetics of drug transporters and its impact on the pharmacotherapy. Curr Top Med Chem 4(13):1383\u20131396","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"3717_CR27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archpsyc.1976.01770090099009","volume":"33","author":"GL Sathananthan","year":"1976","unstructured":"Sathananthan GL, Gershon S, Almeida M, Spector N, Spector S (1976) Correlation between plasma and cerebrospinal levels of imipramine. Arch Gen Psychiatry 33(9):1109","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"3717_CR28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00702-011-0613-x","volume":"118","author":"R Schomburg","year":"2011","unstructured":"Schomburg R, Remane D, Fassbender K, Maurer HH, Spiegel J (2011) Doxepin concentrations in plasma and cerebrospinal fluid. J Neural Transm 118(4):641\u2013645","journal-title":"J Neural Transm"},{"issue":"1","key":"3717_CR29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00007691-200402000-00015","volume":"26","author":"M Shams","year":"2004","unstructured":"Shams M, Hiemke C, H\u00e4rtter S (2004) Therapeutic drug monitoring of the antidepressant mirtazapine and its N-demethylated metabolite in human serum. Ther Drug Monit 26(1):78\u201384","journal-title":"Ther Drug Monit"},{"issue":"1","key":"3717_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00213-007-0877-x","volume":"195","author":"DF Smith","year":"2007","unstructured":"Smith DF, Stork BS, Wegener G, Jakobsen S, Bender D, Hln A, Jensen SB, Hansen SB, Rodell A, Rosenberg R (2007) Receptor occupancy of mirtazapine determined by PET in healthy volunteers. Psychopharmacology 195(1):131\u2013138","journal-title":"Psychopharmacology"},{"issue":"6","key":"3717_CR31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200038060-00001","volume":"38","author":"C Timmer","year":"2000","unstructured":"Timmer C, Sitsen JMA, Delbressine L (2000) Clinical pharmacokinetics of mirtazapine. Clin Pharmacokinet 38(6):461\u2013474","journal-title":"Clin Pharmacokinet"},{"issue":"S2","key":"3717_CR32","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1002\/hup.470100803","volume":"10","author":"G Voortman","year":"1995","unstructured":"Voortman G, Paanakker JE (1995) Bioavailability of mirtazapine from Remeron\u00ae tablets after single and multiple oral dosing. Hum Psychopharmacol Clin Exp 10(S2):S83\u2013S96","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"4","key":"3717_CR33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/dmd.112.050344","volume":"41","author":"K Yasuda","year":"2013","unstructured":"Yasuda K, Cline C, Vogel P, Onciu M, Fatima S, Sorrentino BP, Thirumaran RK, Ekins S, Urade Y, Fujimori K (2013) Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier. Drug Metab Dispos 41(4):923\u2013931","journal-title":"Drug Metab Dispos"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3717-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3717-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T01:41:19Z","timestamp":1565746879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,23]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3717-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,23]]}}}